GRIP Molecular

GRIP is developing an electronic biosensor to provide multi-disease, lab-grade diagnostic results, in minutes, using a standard mobile device.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Minneapolis, MN, USA
  • Currency USD
  • Founded November 2019
  • Employees 7
  • Incorporation Type C-corp
  • Website gripmolecular.com

Company Summary

GRIP Molecular is developing a single-use biosensor and mobile app that provides consumers accurate and actionable medical diagnostic information in minutes, anytime and anywhere. The solid-state electronic technology does not require use of special equipment or chemical reagent processing. GRIP’s first product will simultaneously detect and characterize the immune response to Covid-19, Influenza and other common respiratory disease infections.

Team

  • Edward Gillen
    CEO

    - 30+ years medical device industry experience, including point-of-care diagnostics
    - CEO Medality Medical, strong background in new businesses formation
    - 23-year career at Becton Dickinson (BD)
    - WW Senior Director - Strategy & Business Development - Diabetes Care Division
    - Global VP/GM – Surgical and Anesthesia Systems ($200M P&L) and Advanced Drug Delivery
    - MBA – Penn State University

  • Bruce Batten
    Founder and President

    - 30+ years of general management experience
    - 10+ years of molecular diagnostic development, including POC Zika virus assay
    - C -level roles at Thermo Instruments, CyberOptics and Advantek
    - Founder and CEO of four technology start-ups
    - Faculty of Harvard, Tufts and The Ohio State Medical Schools
    - Ph.D. Anatomy & Cell Biology – Medical College of Virginia, post-doctoral - Harvard Medical School

  • Richard Minicus
    CFO

    - Extensive business development and finance experience in M&A, venture capital investment, and capital markets transactions
    - 21 years in medical technology business development with Becton Dickinson, BD Ventures, and Pfizer
    - 9 years in finance with Merrill Lynch Capital Markets, ML Venture Capital, and JP Morgan
    - MBA - Harvard Business School, MS Biology - Fairleigh Dickinson University, BA Amherst College

  • Stasia Ogden
    General Counsel

    - 20+ years practicing attorney in law firms and major multi-national corporations
    - Focus on healthcare industry global IP strategy, transactions, licensing, litigation and global portfolio management
    - 9 years with Baxter Healthcare Corporation and 4 years with Becton Dickinson
    - JD – Georgetown University

Advisors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free